Literature DB >> 20739397

Defective gonadotropin-dependent ovarian folliculogenesis and granulosa cell gene expression in inhibin-deficient mice.

Ankur K Nagaraja1, Brooke S Middlebrook, Saneal Rajanahally, Michelle Myers, Qinglei Li, Martin M Matzuk, Stephanie A Pangas.   

Abstract

Inhibin-α knockout (Inha-/-) female mice develop sex cord-stromal ovarian cancer with complete penetrance and previous studies demonstrate that the pituitary gonadotropins (FSH and LH) are influential modifiers of granulosa cell tumor development and progression in inhibin-deficient females. Recent studies have demonstrated that Inha-/- ovarian follicles develop precociously to the early antral stage in prepubertal mice without any increase in serum FSH. These studies suggest that in the absence of inhibins, granulosa cells differentiate abnormally and thus at sexual maturity may undergo an abnormal response to gonadotropin signaling contributing to tumor development. To test this hypothesis, we stimulated immature wild-type and Inha-/- female mice with gonadotropin analogs prior to tumor formation and subsequently examined gonadotropin-induced ovarian follicle development as well as preovulatory and human chorionic gonadotropin-induced gene expression changes in granulosa cells. We find that at 3 wk of age, inhibin-deficient ovaries do not show further antral development or undergo cumulus expansion. In addition, there are widespread alterations in the transcriptome of gonadotropin-treated Inha-/- granulosa cells, with significant changes in genes involved in extracellular matrix and cell-cell communication. These data indicate the gonadotropins initiate an improper program of cell differentiation prior to tumor formation in the absence of inhibins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739397      PMCID: PMC2946151          DOI: 10.1210/en.2010-0428

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  65 in total

Review 1.  Cellular basis for paracrine regulation of ovarian follicle development.

Authors:  D F Albertini; C M Combelles; E Benecchi; M J Carabatsos
Journal:  Reproduction       Date:  2001-05       Impact factor: 3.906

2.  Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad.

Authors:  Youngkyu Park; Evelyn T Maizels; Zachary J Feiger; Hena Alam; Carl A Peters; Teresa K Woodruff; Terry G Unterman; Eun Jig Lee; J Larry Jameson; Mary Hunzicker-Dunn
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

3.  Regulated expression of ADAMTS family members in follicles and cumulus oocyte complexes: evidence for specific and redundant patterns during ovulation.

Authors:  JoAnne S Richards; Immaculada Hernandez-Gonzalez; Ignacio Gonzalez-Robayna; Eva Teuling; Yuet Lo; Derek Boerboom; Allison E Falender; Kari H Doyle; Richard G LeBaron; Vivian Thompson; John D Sandy
Journal:  Biol Reprod       Date:  2005-01-19       Impact factor: 4.285

4.  Cyclic guanosine 5'-monophosphate-dependent protein kinase II is induced by luteinizing hormone and progesterone receptor-dependent mechanisms in granulosa cells and cumulus oocyte complexes of ovulating follicles.

Authors:  Venkataraman Sriraman; Michael D Rudd; Suzanne M Lohmann; Sabine M Mulders; JoAnne S Richards
Journal:  Mol Endocrinol       Date:  2005-10-06

5.  Differentiation-dependent expression of connective tissue growth factor and lysyl oxidase messenger ribonucleic acids in rat granulosa cells.

Authors:  R B Slee; S G Hillier; P Largue; C R Harlow; G Miele; M Clinton
Journal:  Endocrinology       Date:  2001-03       Impact factor: 4.736

6.  Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary.

Authors:  M M Reinholz; M A Zschunke; P C Roche
Journal:  Gynecol Oncol       Date:  2000-11       Impact factor: 5.482

7.  Targeted disruption of luteinizing hormone beta-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility.

Authors:  Xiaoping Ma; Yanlan Dong; Martin M Matzuk; T Rajendra Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

8.  Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development.

Authors:  Derek Boerboom; Marilene Paquet; Minnie Hsieh; Jinsong Liu; Soazik P Jamin; Richard R Behringer; Jean Sirois; Makoto M Taketo; Joanne S Richards
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

9.  Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.

Authors:  Corrine K Welt; Ann E Taylor; Janis Fox; Geralyn M Messerlian; Judith M Adams; Alan L Schneyer
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

10.  Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex.

Authors:  Joanne Mayer; Michelle G Hamel; Paul E Gottschall
Journal:  BMC Neurosci       Date:  2005-08-25       Impact factor: 3.288

View more
  11 in total

Review 1.  The TGF-β Family in the Reproductive Tract.

Authors:  Diana Monsivais; Martin M Matzuk; Stephanie A Pangas
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

2.  White Matter Stroke Induces a Unique Oligo-Astrocyte Niche That Inhibits Recovery.

Authors:  Elif G Sozmen; David J DiTullio; Shira Rosenzweig; Jason D Hinman; Sam P Bridges; Miguel Alejandro Marin; Riki Kawaguchi; Giovanni Coppola; S Thomas Carmichael
Journal:  J Neurosci       Date:  2019-10-07       Impact factor: 6.167

3.  The absence of ER-β results in altered gene expression in ovarian granulosa cells isolated from in vivo preovulatory follicles.

Authors:  April K Binder; Karina F Rodriguez; Katherine J Hamilton; Patricia S Stockton; Casey E Reed; Kenneth S Korach
Journal:  Endocrinology       Date:  2013-04-11       Impact factor: 4.736

4.  Microarray analysis identifies COMP as the most differentially regulated transcript throughout in vitro follicle growth.

Authors:  Robin M Skory; Beatriz Peñalver Bernabé; Eugene Galdones; Linda J Broadbelt; Lonnie D Shea; Teresa K Woodruff
Journal:  Mol Reprod Dev       Date:  2013-01-30       Impact factor: 2.609

5.  GDF9 modulates the reproductive and tumor phenotype of female inha-null mice.

Authors:  Michelle Myers; Nadera Mansouri-Attia; Rebecca James; Jia Peng; Stephanie A Pangas
Journal:  Biol Reprod       Date:  2013-04-04       Impact factor: 4.285

6.  TGFβ signaling promotes juvenile granulosa cell tumorigenesis by suppressing apoptosis.

Authors:  Nadéra Mansouri-Attia; Swamy K Tripurani; Nisha Gokul; Hermann Piard; Matthew L Anderson; Karen Eldin; Stephanie A Pangas
Journal:  Mol Endocrinol       Date:  2014-09-22

Review 7.  Metalloproteases in gonad formation and ovulation.

Authors:  Yong Zhu
Journal:  Gen Comp Endocrinol       Date:  2021-10-02       Impact factor: 2.822

8.  Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function.

Authors:  Qinglei Li; Julio E Agno; Mark A Edson; Ankur K Nagaraja; Takashi Nagashima; Martin M Matzuk
Journal:  PLoS Genet       Date:  2011-10-20       Impact factor: 5.917

9.  Expression and cellular distribution of INHA and INHB before and after in vitro cultivation of porcine oocytes isolated from follicles of different size.

Authors:  Bartosz Kempisty; Marta Jackowska; Magdalena Woźna; Paweł Antosik; Hanna Piotrowska; Piotr Zawierucha; Dorota Bukowska; Jędrzej M Jaśkowski; Michał Nowicki; Klaus P Brüssow
Journal:  J Biomed Biotechnol       Date:  2012-11-20

10.  Focused screening of mitochondrial metabolism reveals a crucial role for a tumor suppressor Hbp1 in ovarian reserve.

Authors:  Z Dong; M Huang; Z Liu; P Xie; Y Dong; X Wu; Z Qu; B Shen; X Huang; T Zhang; J Li; J Liu; T Yanase; C Zhou; Y Xu
Journal:  Cell Death Differ       Date:  2016-05-20       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.